• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Research Frontiers Incorporated

    3/15/21 4:15:32 PM ET
    $REFR
    Multi-Sector Companies
    Miscellaneous
    Get the next $REFR alert in real time by email
    SC 13G/A 1 d128090dsc13ga.htm AMENDMENT NO. 6 TO SCHEDULE 13G Amendment No. 6 to Schedule 13G

     

     

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 6)*

     

     

    Research Frontiers Incorporated

    (Name of Issuer)

    Common Stock, $0.0001 par value

    (Title of Class of Securities)

    760911107

    (CUSIP Number of Class of Securities)

    Ryan J. York

    Accretive Legal, PLLC

    23515 NE Novelty Hill Rd., STE B221-334

    Redmond, WA 98053

    (425) 786-9256

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    March 9, 2021

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    SCHEDULE 13G

    CUSIP No. 760911107

     

      1    

      Names of Reporting Persons

      I.R.S. Identification Nos. of above persons (entities only)

     

      Kevin Douglas

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      United States

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      Sole Voting Power

     

      -0-

       6   

      Shared Voting Power

     

      1,232,448 (1)

       7   

      Sole Dispositive Power

     

      -0-

       8   

      Shared Dispositive Power

     

      1,540,569 (1)(2)

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      1,540,569 (1)(2)

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      ☐

    11  

      Percent of Class Represented by Amount in Row (9)

     

      4.8% (1)(2)(3)

    12  

      Type of Reporting Person

     

      IN

     

    (1)

    Kevin Douglas and his wife, Michelle Douglas, hold 380,650 shares and warrants to purchase up to 81,522 shares exercisable within 60 days, jointly as the beneficiaries and co-trustees of the K&M Douglas Trust. In addition, Kevin Douglas and Michelle Douglas are co-trustees of the James Douglas and Jean Douglas Irrevocable Descendants’ Trust which holds 634,407 shares and warrants to purchase up to 135,869 shares exercisable within 60 days.

    (2)

    Kevin Douglas also has dispositive power with respect to 253,773 shares and warrants to purchase up to 54,348 shares exercisable within 60 days, held by the Douglas Family Trust.

    (3)

    Based on 31,650,396 shares of the Issuer’s common stock outstanding as of March 11, 2021, as reported on the Issuer’s 10-K for the year ended December 31, 2020, filed with the Securities and Exchange Commission (the “SEC”) on March 11, 2021.

     

    Page 2 of 9


    SCHEDULE 13G

    CUSIP No. 760911107

     

      1    

      Names of Reporting Persons

      I.R.S. Identification Nos. of above persons (entities only)

     

      Michelle Douglas

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      United States

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      Sole Voting Power

     

       -0-

       6   

      Shared Voting Power

     

      1,232,448 (1)

       7   

      Sole Dispositive Power

     

      -0-

       8   

      Shared Dispositive Power

     

      1,232,448 (1)

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      1,232,448 (1)

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      ☐

    11  

      Percent of Class Represented by Amount in Row (9)

     

      3.9 % (1)(2)

    12  

      Type of Reporting Person

     

      IN

     

    (1)

    Kevin Douglas and his wife, Michelle Douglas, hold 380,650 shares and warrants to purchase up to 81,522 shares exercisable within 60 days, jointly as the beneficiaries and co-trustees of the K&M Douglas Trust. In addition, Kevin Douglas and Michelle Douglas are co-trustees of the James Douglas and Jean Douglas Irrevocable Descendants’ Trust which holds 634,407 shares and warrants to purchase up to 135,869 shares exercisable within 60 days.

    (2)

    Based on 31,650,396 shares of the Issuer’s common stock outstanding as of March 11, 2021, as reported on the Issuer’s 10-K for the year ended December 31, 2020, filed with the SEC March 11, 2021.

     

    Page 3 of 9


    SCHEDULE 13G

    CUSIP No. 760911107

     

      1    

      Names of Reporting Persons

      I.R.S. Identification Nos. of above persons (entities only)

     

      K&M Douglas Trust (1)

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      California

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      Sole Voting Power

     

      -0-

       6   

      Shared Voting Power

     

      462,172 (2)

       7   

      Sole Dispositive Power

     

      -0-

       8   

      Shared Dispositive Power

     

      462,172 (2)

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      462,172 (2)

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      ☐

    11  

      Percent of Class Represented by Amount in Row (9)

     

      1.5% (2)(3)

    12  

      Type of Reporting Person

     

      OO

     

    (1)

    Kevin and Michelle Douglas, husband and wife, are beneficiaries and co-trustees.

    (2)

    Includes 380,650 shares and warrants to purchase up to 81,522 shares exercisable within 60 days.

    (3)

    Based on 31,650,396 shares of the Issuer’s common stock outstanding as of March 11, 2021, as reported on the Issuer’s 10-K for the year ended December 31, 2020, filed with the SEC March 11, 2021.

     

    Page 4 of 9


    SCHEDULE 13G

    CUSIP No. 760911107

     

      1    

      Names of Reporting Persons

      I.R.S. Identification Nos. of above persons (entities only)

     

      Douglas Family Trust (1)

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      California

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      Sole Voting Power

     

      308,121 (2)

       6   

      Shared Voting Power

     

      -0-

       7   

      Sole Dispositive Power

     

      -0-

       8   

      Shared Dispositive Power

     

      308,121 (2)(3)

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      308,121 (2)

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      ☐

    11  

      Percent of class represented by amount in row (9)

     

      * (4)

    12  

      Type of Reporting Person

     

      OO

     

    *

    Less than one percent.

    (1)

    Jean A Douglas is the trustee.

    (2)

    Includes 253,773 shares and warrants to purchase up to 54,348 shares exercisable within 60 days.

    (3)

    Kevin Douglas also has dispositive power with respect to the securities held by the Douglas Family Trust.

    (4)

    Based on 31,650,396 shares of the Issuer’s common stock outstanding as of March 11, 2021, as reported on the Issuer’s 10-K for the year ended December 31, 2020, filed with the SEC March 11, 2021.

     

    Page 5 of 9


    SCHEDULE 13G

    CUSIP No. 760911107

     

      1    

      Names of Reporting Persons

      I.R.S. Identification Nos. of above persons (entities only)

     

      James Douglas and Jean Douglas Irrevocable Descendants’ Trust (1)

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Citizenship or Place of Organization

     

      California

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      Sole Voting Power

     

      770,276 (2)

       6   

      Shared Voting Power

     

      -0-

       7   

      Sole Dispositive Power

     

      770,276 (2)

       8   

      Shared Dispositive Power

     

      -0-

      9    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      770,276 (2)

    10  

      Check if the Aggregate Amount in Row (9) Excludes Certain Shares

     

      ☐

    11  

      Percent of Class Represented by Amount in Row (9)

     

      2.4% (3)

    12  

      Type of Reporting Person

     

      OO

     

    (1)

    Kevin Douglas and Michelle Douglas, husband and wife, are co-trustees.

    (2)

    Includes 634,407 shares and warrants to purchase up to 135,869 shares exercisable within 60 days.

    (3)

    Based on 31,650,396 shares of the Issuer’s common stock outstanding as of March 11, 2021, as reported on the Issuer’s 10-K for the year ended December 31, 2020, filed with the SEC March 11, 2021.

     

    Page 6 of 9


    Item 1.

     

      (a)

    Name of Issuer:

    Research Frontiers Incorporated

     

      (b)

    Address of Issuer’s Principal Executive Offices:

    240 Crossways Park Drive

    Woodbury, New York

    11797

    Item 2.

     

      (1)(a)

    NAME OF PERSONS FILING:

    Kevin Douglas

    Michelle Douglas

     

      (b)

    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

    125 E. Sir Francis Drake Blvd., Ste 400

    Larkspur, CA 94939

     

      (c)

    CITIZENSHIP:

    United States

     

      (d)

    TITLE OF CLASS OF SECURITIES:

    Common Stock, $0.0001 par value

     

      (e)

    CUSIP NUMBER:

    760911107

     

      (2)(a)

    NAME OF PERSONS FILING:

    K&M Douglas Trust

    Douglas Family Trust

    James Douglas and Jean Douglas Irrevocable Descendants’ Trust

     

      (b)

    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

    125 E. Sir Francis Drake Blvd., Ste 400

    Larkspur, CA 94939

     

      (c)

    CITIZENSHIP:

    California

     

      (d)

    TITLE OF CLASS OF SECURITIES:

    Common Stock, $0.0001 par value

     

      (e)

    CUSIP NUMBER:

    760911107

     

    Page 7 of 9


    Item 3.

    If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c), check whether the person filing is a:

     

    (a)   

      

    ☐   

       Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

    (b)   

      

    ☐   

       Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

    (c)   

      

    ☐   

       Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

    (d)   

      

    ☐   

       Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)

    (e)   

      

    ☐   

       An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

    (f)   

      

    ☐   

       An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

    (g)   

      

    ☐   

       A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

    (h)   

      

    ☐   

       A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

    (i) 

      

    ☐   

       A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

    (j) 

      

    ☐   

       Group, in accordance with §240.13d-1(b)(1)(ii)(J)

    Not Applicable.

     

    Page 8 of 9


    Item 4.

    Ownership

    Reference is made as to each of the Reporting Persons hereunder to Rows 5-9 and 11 of each of the cover pages of this Schedule 13G and associated footnotes, which are incorporated by reference herein.

    Each of the Reporting Persons hereunder may be deemed a member of a “group” within the meaning of Section 13(d)(3) of the Exchange Act, or Rule 13d-5 promulgated under the Exchange Act with one or more of the other Reporting Persons hereunder. Although the Reporting Persons are reporting such securities as if they were members of a “group,” the filing of this Schedule 13G shall not be construed as an admission by any Reporting Person that such Reporting Person is a beneficial owner of any securities other than those directly held by such Reporting Person.

     

    Item 5.

    Ownership of Five Percent or Less of a Class

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: ☒

     

    Item 6.

    Ownership of More Than Five Percent on Behalf of Another Person

    Not applicable.

     

    Item 7.

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company

    Not applicable.

     

    Item 8.

    Identification and Classification of Members of the Group

    See Item 4 of this Schedule 13G and the Joint Filing Agreement attached hereto as Exhibit A.

     

    Item 9.

    Notice of Dissolution of Group

    Not applicable.

     

    Item 10.

    Certification

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

    Page 9 of 9


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Date: March 15, 2021    

    * Kevin Douglas

        KEVIN DOUGLAS
    Date: March 15, 2021    

    * Michelle Douglas

        MICHELLE DOUGLAS
        K&M DOUGLAS TRUST
    Date: March 15, 2021    

    * Kevin Douglas

        By:   Kevin Douglas
        Title:   Trustee
    Date: March 15, 2021    

    * Michelle Douglas

        By:   Michelle Douglas
        Title:   Trustee
        DOUGLAS FAMILY TRUST
    Date: March 15, 2021    

    * Jean A. Douglas

        By:   Jean A. Douglas
        Title:   Trustee
        JAMES DOUGLAS AND JEAN DOUGLAS
        IRREVOCABLE DESCENDANTS’ TRUST
    Date: March 15, 2021    

    * Kevin Douglas

        By:   Kevin Douglas
        Title:   Trustee
    Date: March 15, 2021    

    * Michelle Douglas

        By:   Michelle Douglas
        Title:   Trustee

     

    *By:  

    /s/ Eileen Wheatman

      Eileen Wheatman
      Attorney-in-fact
    Get the next $REFR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $REFR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $REFR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Research Frontiers Incorporated

      SC 13G - RESEARCH FRONTIERS INC (0000793524) (Subject)

      1/25/24 9:15:55 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form SC 13G filed by Research Frontiers Incorporated

      SC 13G - RESEARCH FRONTIERS INC (0000793524) (Subject)

      10/19/23 3:59:29 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form SC 13G/A filed by Research Frontiers Incorporated

      SC 13G/A - RESEARCH FRONTIERS INC (0000793524) (Subject)

      3/15/21 4:15:32 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous

    $REFR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by VP-Marketing Lapointe Michael R

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      1/2/25 6:48:01 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 4 filed by President and CEO Harary Joseph M

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      1/2/25 6:48:02 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 4 filed by Director Daigle Darryl

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      1/2/25 6:48:00 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous

    $REFR
    Leadership Updates

    Live Leadership Updates

    See more

    $REFR
    SEC Filings

    See more
    • Eyal Peso, CEO of Smart Materials Company Gauzy, Ltd. Joins Board of Directors of Smart Glass Leader Research Frontiers

      Woodbury, New York and Tel Aviv/Jaffo, June 05, 2023 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (NASDAQ:REFR) and Gauzy Ltd. announced today the appointment of Eyal Peso to the Research Frontiers Board of Directors effective June 4, 2023. Mr. Peso, age 43, is the Co-Founder, Chairman of the Board of Directors and CEO of smart materials manufacturer Gauzy, Ltd. Joseph M. Harary, President and CEO of Research Frontiers noted: "Eyal Peso has been a transformational force in our industry. From our first meeting, we shared the same vision of what the smart glass industry should become, and together we have worked hard, and have invested considerable resources, to bring the best performing

      6/5/23 8:30:00 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • PDS Biotechnology Appoints Seth Van Voorhees as Chief Financial Officer

      FLORHAM PARK, N.J., Dec. 09, 2020 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced the appointment of Seth Van Voorhees, Ph.D. as its new Chief Financial Officer effective January 1, 2021. “Dr. Van Voorhees is a highly accomplished CFO with extensive experience in corporate finance, capital markets, investment banking and licensing. His appointment comes at a time of significant opportunity and growth for our Company. His business and financial expertise will be instrumental in

      12/9/20 8:30:00 AM ET
      $REFR
      $PDSB
      Multi-Sector Companies
      Miscellaneous
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • SEC Form 10-Q filed by Research Frontiers Incorporated

      10-Q - RESEARCH FRONTIERS INC (0000793524) (Filer)

      5/8/25 4:01:43 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • SEC Form DEF 14A filed by Research Frontiers Incorporated

      DEF 14A - RESEARCH FRONTIERS INC (0000793524) (Filer)

      4/30/25 4:01:23 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form 10-K/A filed by Research Frontiers Incorporated

      10-K/A - RESEARCH FRONTIERS INC (0000793524) (Filer)

      4/15/25 6:05:34 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous

    $REFR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Research Frontiers Reports First Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today

      WOODBURY, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.  •Who: Joseph M. Harary, President & CEO •Date/Time: Thursday, May 8, 2025, 4:30 PM ET •Dial-in Information:1-888-334-5785 •Conference Link: https://join.broaddata.com/?id=research-frontiers •Replay: Available on Friday, May 9, 2025 for 90 days at https://smartglass-ir.com Key Comments: 1.Strong Revenue Growth in the Automotive and Aircraft MarketsResearch Frontiers royalty income increased by

      5/8/25 4:01:00 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • RESEARCH FRONTIERS TO HOST FIRST QUARTER 2025 CONFERENCE CALL

      WOODBURY, NY, May 05, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025. Research Frontiers will host a conference call at 4:30 p.m. Eastern Time on Thursday, May 8, 2025 to discuss its first quarter 2025 financial and operating results, as well as recent developments. Who: Joseph M. Harary, President & CEODate/Time: Thursday, May 8, 2025, 4:30 PM ETDial-in Information: 1-888-334-5785Conference Link: https://join.broaddata.com/?id=research-frontiersQuestions: Email to [email protected]: Available on Friday, May 9, 2025 for 90 days at https://smartglass-ir.com/

      5/5/25 8:30:00 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Gauzy's State-of-The-Art Smart Glass Technologies Utilized in the Mercedes-Benz Vision V Show Car, Unveiled at Auto Shanghai 2025

      Mercedes-Benz Chooses Gauzy's Dual Smart Glass Technology Stack, Combining both SPD & PDLC, Highlighting the Evolution of Automotive Smart Glass Integration by Mercedes-Benz. Approximately 75% of the Show Cars' Vehicle Glazing Includes Gauzy's Dual Smart Glass Stack, Showcasing the Widespread Applications and Benefits of this Technology When Used Throughout a Vehicle. Solidifies Mercedes-Benz and Gauzy's Continued Partnership, and Underscores Mercedes-Benz's Commitment to Bring State-of-the-Art Technologies into Innovative Show Cars. Photo Credit: Mercedes-Benz TEL AVIV, Israel, April 23, 2025 (GLOBE NEWSWIRE) -- Gauzy Ltd. (NASDAQ:GAUZ), a global leader in light and vision control t

      4/23/25 7:30:00 AM ET
      $GAUZ
      $REFR
      Industrial Machinery/Components
      Miscellaneous
      Multi-Sector Companies

    $REFR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Kaganowicz Alexander bought $3,880 worth of shares (2,000 units at $1.94), increasing direct ownership by 1% to 164,923 units (SEC Form 4)

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      6/17/24 6:30:05 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Daigle Darryl bought $7,482 worth of shares (4,300 units at $1.74) (SEC Form 4)

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      6/10/24 6:04:49 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Daigle Darryl bought $1,000 worth of shares (1,000 units at $1.00) (SEC Form 4)

      4 - RESEARCH FRONTIERS INC (0000793524) (Issuer)

      2/8/24 5:50:48 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous

    $REFR
    Financials

    Live finance-specific insights

    See more
    • Research Frontiers Reports First Quarter 2025 Financial Results and Will Host a Conference Call at 4:30p.m. Today

      WOODBURY, N.Y., May 08, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2025. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.  •Who: Joseph M. Harary, President & CEO •Date/Time: Thursday, May 8, 2025, 4:30 PM ET •Dial-in Information:1-888-334-5785 •Conference Link: https://join.broaddata.com/?id=research-frontiers •Replay: Available on Friday, May 9, 2025 for 90 days at https://smartglass-ir.com Key Comments: 1.Strong Revenue Growth in the Automotive and Aircraft MarketsResearch Frontiers royalty income increased by

      5/8/25 4:01:00 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • RESEARCH FRONTIERS TO HOST FIRST QUARTER 2025 CONFERENCE CALL

      WOODBURY, NY, May 05, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its first quarter 2025 financial results on Thursday, May 8, 2025. Research Frontiers will host a conference call at 4:30 p.m. Eastern Time on Thursday, May 8, 2025 to discuss its first quarter 2025 financial and operating results, as well as recent developments. Who: Joseph M. Harary, President & CEODate/Time: Thursday, May 8, 2025, 4:30 PM ETDial-in Information: 1-888-334-5785Conference Link: https://join.broaddata.com/?id=research-frontiersQuestions: Email to [email protected]: Available on Friday, May 9, 2025 for 90 days at https://smartglass-ir.com/

      5/5/25 8:30:00 AM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous
    • Research Frontiers Reports 2024 Financial Results and Will Host a Conference Call at 4:30p.m. Today

      WOODBURY, N.Y., March 06, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its fourth quarter and full-year 2024. Management will host a conference call today at 4:30 p.m. Eastern Time to discuss its financial and operating results as well as recent developments.  •Who: Joseph M. Harary, President & CEO •Date/Time: Thursday, March 6, 2025, 4:30 PM ET •Dial-in Information:1-888-334-5785 •Replay: Available on Friday, March 7, 2025 for 90 days at https://smartglass-ir.com/    Key Comments: 1.Revenue Growth in the Automotive and Aircraft MarketsResearch Frontiers royalty income increased by 47% in 2024 to $1,335,531 compared to $909,598 in 202

      3/6/25 4:01:00 PM ET
      $REFR
      Multi-Sector Companies
      Miscellaneous